RW
Regan William John
About Regan William John
Data last updated:
Regan William John has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Likameda Pharmaceuticals Private Limited. Formerly with 1 company, such as Likameda Global Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Likameda Pharmaceuticals Private Limited at ₹2.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Jun 2021 | 2021 | ₹2.26 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Mar 2023 | 2020 | ₹84.6 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Regan William John
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Regan William John
Regan William John has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Likameda Pharmaceuticals Private Limited. Formerly with 1 company, such as Likameda Global Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Likameda Pharmaceuticals Private Limited at ₹2.26 Cr (FY 2025).
Regan William John is associated with 1 company as Director, including Likameda Pharmaceuticals Private Limited (₹2.26 Cr).
Regan William John has expertise in General Business.
Regan William John has 5 years in corporate governance.
By reported revenue, the largest current company of Regan William John is Likameda Pharmaceuticals Private Limited, with revenue of ₹2.26 Cr (FY 2025).
Regan William John currently holds positions at 1 company: Likameda Pharmaceuticals Private Limited (₹2.26 Cr).